DC Business DC

Novavax names manufacturing partner for flu vaccine

Washington Business Journal

Mar 31, 2020

Emergent BioSolutions Inc. has inked another deal with fellow Gaithersburg biotech Novavax Inc. - this time, for its seasonal flu vaccine. The agreement means Emergent (NYSE: EBS)…

Read the full story at Washington Business Journal

Topics

#Biotech

Novavax names manufacturing partner for flu vaccine

Topics

More from DC Business

Shilling Canning files for bankruptcy protection amid rent struggles

Steve Case's Revolution teams with Hilton to deliver luxury Costa Rican resort 19 years in the making

Challenge to ACA preventive-care panel draws skepticism from Supreme Court

Can Trump remove Powell as Fed chair before his term ends?

Amazon closing one of its Northern Virginia supermarkets

International travelers give D.C.'s hospitality business only slight boost

Drone firm announces Virginia expansion and college partnership

Mixed-use development in downtown Bethesda looks to add more retail, residences